Skip to main content
. 2023 Nov 30;19(11):e1011043. doi: 10.1371/journal.pgen.1011043

Fig 5. A composite origin of APOBEC3 signature mutations in breast cancer.

Fig 5

An unsupervised clustering analysis of similarity between the pentanucleotide SBS profiles from WGSs of the A3A, A3B, and control granddaughter clones described here versus those from primary breast tumor whole-genome sequencing data sets (ICGC, n = 784). The APOBEC3 mutation signature is represented by both enrichment score and SBS2+13 (red), HRD signature as SBS3 (blue), and ageing signature as SBS1 (gray).